LNXRNA
Live / Applied — Non-final action mailed (as of 21 Jul 2026)
What this means for you
Not registered yet, but its 17 Apr 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99770950
- Mark type
- Word mark
- Filed
- 17 Apr 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, therapeutic agents, and pharmaceutical products for RNA medicines
- Class 042 — Scientific and technological services: development of new technology for enabling the engineering and modification of RNA, such as developing molecular and cellular biology reagents, products, techniques, and assays for the modification of cells and RNA
Owner
- Aera Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 21 Jul 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jul 2026 — NON-FINAL ACTION E-MAILED
- 21 Jul 2026 — NON-FINAL ACTION WRITTEN
- 20 Jul 2026 — ASSIGNED TO EXAMINER
- 17 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 17 Apr 2026 — NEW APPLICATION ENTERED